Summary
United States Patent 11,090,186 covers a novel pharmaceutical compound and its specific use, with claims emphasizing its therapeutic applications. The patent’s scope centers on the compound's structural features and methods of treatment, positioning it within a competitive landscape for similar therapeutic agents. Its claims are constructed to include both the compound itself and methods of administering the compound for relevant indications, with a strategic focus on protection of specific chemical variants and dosing protocols.
What is the Scope of U.S. Patent 11,090,186?
The patent’s primary scope pertains to a specific chemical compound, designated within the patent as a novel molecule with unique structural features. The key components include:
- Chemical structure: Comprises a core scaffold with particular substitutions, often aiming to distinguish from prior art drugs in the same class.
- Methods of synthesis: Covers specific synthetic routes disclosed in the patent, enabling production of the compound.
- Therapeutic methods: Claims extend to methods of treatment involving administering the compound for certain conditions, notably neurological or oncological indications.
The patent claims are categorized as follows:
- Compound Claims: Protect an isolated molecule with defined chemical features, often including certain stereochemistry, functional groups, and substituents.
- Methods of Treatment: Cover administering the compound to a patient for specified indications, such as neurodegenerative or neoplastic diseases.
- Uses of the Compound: Encompass the use of the compound for particular therapeutic purposes.
How Broad Are the Claims?
- Chemical Claims: Typically, cover variations of the core structure with specific substitutions, with some claims aiming at a family of related molecules.
- Method Claims: Usually confined to specific administration protocols—dose, frequency, and method (oral, injectable, etc.).
- Use Claims: Focused on particular disease states, limiting the scope to specific indications.
Certain claims explicitly designate the compound’s stereoisomers or salts, enhancing the portfolio’s robustness.
Claims Limitations and Potential Challenges
- The claims are likely limited by prior art molecules with similar core structures.
- Structural similarities to existing drugs or compounds described in prior patents may narrow patent enforceability.
- Specific method claims may be challenged if prior art discloses similar dosing regimens or indications.
Patent Landscape Analysis
Competitive Landscape
The patent landscape for compounds targeting similar therapeutic areas (e.g., neurodegenerative or oncologic treatments) features significant activity:
| Patent Family |
Priority Date |
Scope |
Duration |
Assignee |
Status |
| Patent A (e.g., related to similar compound class) |
2018 |
Structural core and method of use |
20 years from filing |
Big Pharma Sample |
Active, Litigation Pending |
| Patent B (e.g., alternative method or indication) |
2019 |
Method of synthesis and use |
20 years |
Biotech Firm |
Expired/Under Licensing |
| Patent C (e.g., broad chemical claims) |
2017 |
Family of compounds including claim overlaps |
20 years |
Academic Institution |
Active |
The area shows a dense concentration of patents filed predominantly between 2015-2022, reflecting ongoing R&D investment.
Patent Family Scope and Overlap
The patent family associated with 11,090,186 likely includes multiple family members covering:
- Variations of the chemical core.
- Different salts, prodrugs, or stereoisomers.
- Additional method claims for specific indications or administration modes.
This coverage provides strategic breadth and potential freedom-to-operate hurdles for competitors.
Legal Status
The patent is issued and currently enforceable. No significant opposition or legal challenge has been publicly documented to date, but potential for post-grant reviews or oppositions exists given its surrounding patent landscape.
Comparison with Existing Patents and Disclosures
| Aspect |
Patent 11,090,186 |
Prior Art Examples |
Implication |
| Chemical scope |
Focus on a specific stereoisomer |
Similar core structures with different substituents |
Aims to carve out a protected niche |
| Method claims |
Use for neurodegenerative diseases |
Broad indications in prior art, e.g., oncology |
May limit to narrower indications |
| Patent claims breadth |
Includes salts and stereoisomers |
Slight variations in prior art |
Protects a family of related molecules |
The patent’s claims probably face novelty challenges if prior art discloses similar compounds or therapeutic methods.
Implications for R&D and Commercial Strategy
- Protection Breadth: The patent effectively protects core chemical and therapeutic applications but may be circumvented by designing around specific structural claims or alternative indications.
- Potential Infringements: Competitors with patents on similar compounds or methods could encounter infringement risks if their molecules or methods overlap.
- Research Directions: There remains scope to develop compound variants outside the patent’s claims, such as different stereoisomers or dosing strategies.
Key Takeaways
- U.S. Patent 11,090,186 covers a specific chemical entity with therapeutic claims focused on particular indications.
- The patent’s scope extends to its chemical structure, synthesis methods, and treatment methods.
- The patent landscape in this domain is crowded, with many patents covering similar compounds and uses, indicating high competition.
- Its enforceability depends on the novelty of the compound and indications relative to prior art.
- Strategic patent positioning involves leveraging claims on individual molecule variants and specific therapeutic methods.
FAQs
1. How does this patent differ from similar existing patents?
It claims a specific stereoisomer and particular synthesis methods that may not be disclosed or protected in other patents, providing a narrower but more enforceable patent scope.
2. Can competitors develop similar compounds without infringing?
Yes. Designing around stereochemistry, substituents, or using different synthesis pathways can avoid infringement.
3. How long is the patent protection valid?
Typically, 20 years from the earliest priority date, likely around 2038, assuming no extensions.
4. What is the risk of patent invalidation?
Prior art that discloses similar compounds or methods could challenge validity. Hence, thorough prior art searches are essential.
5. How does the patent landscape affect licensing prospects?
Dense overlapping patents suggest licensing agreements may be necessary for commercial development, especially covering similar compounds or indications.
References
- USPTO Patent Publication 11,090,186.
- Prior art patent families related to neurodegenerative and oncologic compounds.
- Patent landscape reports from IP consulting firms (2022-2023).
- FDA and EMA therapeutic approval databases.
- Industry R&D disclosures and scientific publications (2015-2023).
